Phase 2 Clinical Trial of Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers

類似資料

• Optimization of Plasmid Maintenance in the Attenuated Live Vector Vaccine Strain Salmonella typhi CVD 908-htrA
  著者:: Galen, James E., 等
  出版事項: (1999)
• Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.
  著者:: Tacket, C O, 等
  出版事項: (1997)
• Expression and Immunogenicity of a Mutant Diphtheria Toxin Molecule, CRM(197), and Its Fragments in Salmonella typhi Vaccine Strain CVD 908-htrA
  著者:: Orr, Nadav, 等
  出版事項: (1999)
• Adaptation of the Endogenous Salmonella enterica Serovar Typhi clyA-Encoded Hemolysin for Antigen Export Enhances the Immunogenicity of Anthrax Protective Antigen Domain 4 Expressed by the Attenuated Live-Vector Vaccine Strain CVD 908-htrA
  著者:: Galen, James E., 等
  出版事項: (2004)
• Helicobacter pylori Infection Affects Immune Responses Following Vaccination of Typhoid-Naive US Adults With Attenuated Salmonella Typhi Oral Vaccine CVD 908-htrA
  著者:: Muhsen, Khitam, 等
  出版事項: (2014)